Smith & Nephew (SN.)

Sector:

Health Care

Index:

FTSE 100

964.40p
   
  • Change Today:
    -19.00p
  • 52 Week High: 1,314.50
  • 52 Week Low: 896.20
  • Currency: UK Pounds
  • Shares Issued: 874.33m
  • Volume: 3,025,966
  • Market Cap: £8,432m
  • RiskGrade: 173

Geographical - by origin

  31-Dec-2331-Dec-2231-Dec-2131-Dec-2031-Dec-19
Revenue
Unanalysedn/an/an/an/an/an/a4,560.00100%n/an/a
Total 5,549.00n/a 5,215.00n/a 5,212.00n/a 4,560.00100% 5,138.00n/a 
 
Profit Before Tax
Unanalysedn/an/an/an/an/an/a246.00100%n/an/a
Total 290.00n/a 235.00n/a 586.00n/a 246.00100% 743.00n/a 

Geographical - by origin (turnover)

Product breakdown (turnover)

Product breakdown

  31-Dec-2331-Dec-2231-Dec-2131-Dec-2031-Dec-19
Revenue
Advanced Wound Managemenn/an/an/an/an/an/a1,310.0029%n/an/a
Advanced Wound Management1,606.0029%1,512.0029%1,496.0029%n/an/a1,380.0027%
Orthopaedics2,214.0040%2,113.0041%2,156.0041%1,917.0042%2,222.0043%
Sports Medicine & ENT1,729.0031%1,590.0030%1,560.0030%1,333.0029%1,536.0030%
Total 5,549.00100% 5,215.00100% 5,212.00100% 4,560.00100% 5,138.00100% 
 
Profit Before Tax
Unanalysed290.00n/a235.00n/a586.00n/a246.00n/a743.00n/a
Total 290.00n/a 235.00n/a 586.00n/a 246.00n/a 743.00n/a 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: Forecast figures based on normalised accounts.

 

Top of Page